Antimicrobial resistance (AMR) is a major global health threat. Aidian takes part in supporting antimicrobial stewardship and sustainable us...

The new In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR) entered into application on 26 May 2022. The new regulation will...

HemoScreen™ is a portable point of care hematology analyzer that combines flow cytometry and digital imaging in a single platform for CBC an...

Infectious diarrheas are a major cause of morbidity and mortality worldwide, mainly in young children, the elderly, and the immunocompromise...

We are happy to announce that the Norwegian family-owned investment company Ferd will come as a co-owner of Aidian together with Nordstjerna...

Viruses are major causes of upper respiratory tract infections (URTIs). Yet, antibiotics are commonly prescribed for URTIs. Even if, the flu...

We have updated our website with a new sustainability section. You can now find more information about sustainability at Aidian, our commitm...